Maswikiti Ewetse Paul, Feng Zedong, Yin Zhenyu, Zhang Fan, He Lijuan, Gu Baohong, Xiang Lin, Li Huixia, Wang Caijuan, Yu Yang, Xu Bo, Wang Jize, Chen Hao
Surgical Oncology Department, Lanzhou University Second Hospital, Lanzhou, China.
Department of Pathology, Lanzhou University Second Hospital, Lanzhou, China.
Front Immunol. 2025 Apr 29;16:1556493. doi: 10.3389/fimmu.2025.1556493. eCollection 2025.
Angiosarcomas are sporadic vascular neoplasms among the most aggressive subtypes of soft tissue sarcomas. In addition, vast and multiple recurrent superficial scalp and facial angiosarcomas are very complex and extremely difficult to manage. Their occurrence brings about significant social and emotional distress to affected individuals. To date, no specific therapeutic strategy has been the most effective and reliable. Herein, we report a highly unique case of a geriatric male patient with recurrent scalp and facial angiosarcoma successfully treated by a chemotherapy-free regimen consisting of photodynamic therapy (PDT), immunotherapy, and target therapy. Notably, PDT provided promising remarkable auspicious outcomes and proved to be a better therapeutic option for refractory malignant angiosarcomas.
血管肉瘤是散发性血管肿瘤,属于软组织肉瘤中侵袭性最强的亚型。此外,广泛且多发的复发性浅表头皮和面部血管肉瘤非常复杂,极难处理。它们的发生给患者带来了巨大的社会和情感困扰。迄今为止,尚无特定的治疗策略是最有效和可靠的。在此,我们报告了一例极为独特的老年男性复发性头皮和面部血管肉瘤患者,通过由光动力疗法(PDT)、免疫疗法和靶向疗法组成的无化疗方案成功治愈。值得注意的是,光动力疗法带来了显著且良好的效果,被证明是难治性恶性血管肉瘤的更佳治疗选择。